Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NIDA P50 DA13333 | |||
| P50DA013333 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study evaluates the effect of smoking reduction vs usual care (quitting advice only) for individuals with peripheral arterial disease who smoke.
This study randomly assigns smokers who do not have a quit date set to either a smoking reduction grop or usual care group. The smoking reduction group receives behavioral counseling on smoking reduction and nicotine patch and/or gum to reduce the number of cigarettes smoked per day by at least 50%. The usual care group is given brief advice to quit smoking and referral to local cessation services. To be included in the study, participants must have peripheral arterial disease (defined as ankle Brachial Index equal to or less than 0.85 or history of prior revascularization) and they must be daily smokers (defined as at least 1 cigarette, cigar, or tobacco pipe daily). Participants complete questionnaires that measure mood, functional ability, smoking history, and motivation to quit smoking. Participants will be followed in this study for up to 24 months.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Other | Usual care |
|
| 2 | Other | Reduction |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nicotine replacement | Drug | For reduction |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of cigarettes per day | 6 months | |
| ASCVD health changes | 6 months | |
| Days of abstinence from cigarettes | 6 months | |
| Number of quit attempts | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Withdrawal symptoms | ongoing through 6 months |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anne Joseph, MD | Veteran's Administration Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Univeristy of Minnesota | Minneapolis | Minnesota | 55404 | United States | ||
| Univerisity of Minnesota |
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D014029 | Tobacco Use Disorder |
| D016540 | Smoking Cessation |
| D000074264 | Smoking Reduction |
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
| D015438 | Health Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D000095488 | Nicotine Replacement Therapy |
| D009538 | Nicotine |
| D001521 | Behavior Therapy |
| ID | Term |
|---|---|
| D004358 | Drug Therapy |
| D013812 | Therapeutics |
| D012991 | Solanaceous Alkaloids |
| D000470 | Alkaloids |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Motivational counseling | Behavioral | No drugs |
|
|
| Minneapolis |
| Minnesota |
| 55414 |
| United States |
| D001519 | Behavior |
| D012907 | Smoking |
| D006571 |
| Heterocyclic Compounds |
| D011725 | Pyridines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |